1. 197Inhibition of TASK-1 by gene therapy and pharmacological compounds suppresses atrial fibrillation in a large animal model. (28th August 2018) Authors: Schmidt, C; Wiedmann, F; Beyersdorf, C; Zhao, Z; El-Battrawy, I; Li, X; Lang, S; Rapti, K; Jungmann, A; Mueller, O; Zhou, X; Borggrefe, M; Katus, H; Thomas, D Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P236Evaluation of safety and feasibility of Mybpc3 gene therapy in a mouse model of hypertrophic cardiomyopathy. (15th July 2014) Authors: Mearini, G; Simpel, D; Geertz, B; Kraemer, L; Schlossarek, S; Weinberger, F; Mueller, O; Voit, T; Eschenhagen, T; Carrier, L Journal: Cardiovascular research Issue: Volume 103(2014)Supplement 1 Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P317Tight regulation of RANKL through OPG in the development of inflammatory cardiomyopathy. (23rd April 2018) Authors: Fischer, A; Stroikova, V; Bockstahler, M; Mueller, A M; Hill, P P; Oettl, R; Mueller, O; Katus, H A; Kaya, Z Journal: Cardiovascular research Issue: Volume 114(2018)Supplement 1 Page Start: S81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗